ACOR
Acorda Therapeutics
ACOR
ACOR
Delisted
ACOR was delisted on the 11th of April, 2024.
162 hedge funds and large institutions have $1.22B invested in Acorda Therapeutics in 2018 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 53 increasing their positions, 43 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
8% more funds holding
Funds holding: 150 → 162 (+12)
57% less call options, than puts
Call options by funds: $17.2M | Put options by funds: $39.5M
Holders
162
Holding in Top 10
2
Calls
$17.2M
Puts
$39.5M
Top Buyers
| 1 | +$18.2M | |
| 2 | +$12.7M | |
| 3 | +$8.8M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$7.93M |
| 5 |
Renaissance Technologies
New York
|
+$4.91M |
Top Sellers
| 1 | -$25.2M | |
| 2 | -$7.38M | |
| 3 | -$7.38M | |
| 4 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$5.35M |
| 5 |
D.E. Shaw & Co
New York
|
-$4.77M |